-
61
Engineered ipilimumab variants that bind human and mouse CTLA-4
Published 2025-12-01Get full text
Article -
62
-
63
-
64
-
65
Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
Published 2025-12-01Get full text
Article -
66
-
67
-
68
-
69
Early warning systems for identifying severe maternal outcomes: findings from the WHO global maternal sepsis studyResearch in context
Published 2025-01-01“…Funding: UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Merck for Mothers, U.S. Agency for International Development, Wellcome Trust, and National Institute for Health and Care Research.…”
Get full text
Article -
70
Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatmentResearch in context
Published 2025-02-01“…Funding: This work was supported by a Grant for Multiple Sclerosis Innovation by Merck KGaA (ID: 10.12039/100009945).…”
Get full text
Article